• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Special Reports
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Resources
    • About MassDevice
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
    • In-Depth Coverage
    • Latest News
  • Attend DeviceTalks
    • Events
      • DeviceTalks Minnesota – May 4
      • DeviceTalks Boston – May 27–28
      • DeviceTalks West
      • DeviceTalks Tuesdays
    • DeviceTalks Podcast Network
      • DeviceTalks Weekly
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Advertise
  • Subscribe
Home » Johnson & Johnson’s Ethicon settles more Physiomesh suits

Johnson & Johnson’s Ethicon settles more Physiomesh suits

December 5, 2023 By Chris Newmarker

This image shows the logo of the Ethicon surgical devices business of Johnson & Johnson.Johnson & Johnson has settled more than 200 cases remaining in a multi-district litigation over hernia mesh made by its Ethicon subsidiary.

U.S. District Court Judge Richard Story in Northern Georgia on Dec. 1 agreed to dismiss the cases with prejudice at the request of lawyers for both sides. The lawyers had informed him that they had compromised and settled all claims between them, including all counterclaims, cross-claims and third-party claims.

There were no additional details about the settlement in the court documents.

In a statement shared by a spokesperson, Ethicon said:

“While we empathize with any patients who experience medical complications from surgery, our company acted appropriately and responsibly in the research, development and marketing of its hernia mesh products which have been used to care for millions of patients around the world for more than 50 years. This settlement is not an admission of liability or wrongdoing and was agreed to in the best interests of all parties to avoid a prolonged legal process and allow us to continue to focus on helping patients, including those requiring hernia treatment, to live their best lives.”

The lawsuits arose out of Johnson & Johnson’s 2016 recall of Physiomesh flexible composite hernia mesh. The company said at the time that it decided on the recall after studies showed higher revision rates after a type of minimally invasive hernia repair using Physiomesh.

According to Johnson & Johnson’s most recent annual report, thousands of lawsuits followed in federal courts, with the cases organized as a multi-district litigation (MDL) in the U.S. District Court in Northern Georgia. There was also the formation of a multi-county litigation (MCL) in Atlantic County, New Jersey.

In May 2021, J&J’s Ethicon entered into a term sheet to resolve roughly 3,600 Physiomesh cases, involving roughly 4,300 plaintiffs in the MDL and MCL. In September 2021, the company entered into a resulting master settlement agreement that included 3,729 cases in the MDL and MCL.

Of the cases subject to the master settlement agreement, 2,236 had been dismissed with prejudice by the start of 2023. However, more than 200 cases remained active because they were subject to docket control orders requiring early expert reports and discovery requirements. Those remaining cases now appear to have been settled.

Filed Under: Featured, Legal News, News Well, Product Liability, Surgical Tagged With: Ethicon, Johnson & Johnson

More recent news

  • Perfuze’s super-bore stroke catheter tops conventional, cyclic aspiration in bench study
  • Edwards Lifesciences taps GE HealthCare vet to head new digital engineering group
  • Abbott partners with Berry Street to add nutrition coaching to Lingo
  • GE HealthCare taps retiring AT&T CFO for board of directors
  • Corcym delivers first-in-human implant of Memo 4D Curve mitral repair ring

About Chris Newmarker

Chris Newmarker is the executive editor of WTWH Media life science's news websites and publications including MassDevice, Medical Design & Outsourcing and more. A professional journalist of 18 years, he is a veteran of UBM (now Informa) and The Associated Press whose career has taken him from Ohio to Virginia, New Jersey and, most recently, Minnesota. He’s covered a wide variety of subjects, but his focus over the past decade has been business and technology. He holds bachelor’s degrees in journalism and political science from Ohio State University. Connect with him on LinkedIn or email at [email protected].

Primary Sidebar

Cart

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >
MDO ad
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2026 · Arrowfly LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy